[Treatment of systemic lupus erythematosus with intravenous human immunoglobulins. Preliminary study].
Recently the availability of human immunoglobulin for intravenous use (IVIg) has been helpful in the treatment of some conditions characterized by autoimmune disorders and anecdotal reports have been suggested a favourable role in the therapy of SLE. We report our experience on 4 SLE patients in whom IVIg was administered. Our data suggest that IVIg may be considered an alternative regimen to treat selected patients affected by SLE.